EUVIMED · CrossrefZeitschrift
Translational Oncology
ISSN 1936-5233 · Elsevier BV
Neueste Artikel
Exercise enhances cancer immunotherapy by reshaping systemic T cell homeostasis
Analytical and clinical validation of Ion Torrent™ Oncomine™ Dx Express Test for identifying PIK3CA/AKT1/PTEN-altered tumors in patients with hormone receptor-positive advanced breast cancer for treatment with capivasertib
Clinical implications of morular metaplasia in fertility-preserving treatment for young patients with endometrial hyperplasia and atypical endometrial hyperplasia: a retrospective cohort study
CD74 links MHC class II risk to tumor immune microenvironment remodeling across the Sjögren-to-lymphoma axis
PAQR5 links microvascular invasion, innate immune inflammatory amplification, and platinum resistance in ovarian cancer
BGN marks cancer-associated fibroblast activation and extracellular matrix remodeling in HNSCC
Fecal microbiota capsule transplantation plus immunotherapy as first-line maintenance therapy for patients with malignant solid tumors: A single-arm, dose-escalation, exploratory phase I study
HAUS5 defines a mitogen-activated protein kinase/extracellular signal-regulated kinase-dependent epithelial–mesenchymal plasticity program and therapeutic vulnerability to Belinostat in clear cell renal cell carcinoma
FOXO3a suppression predicts poor prognosis and facilitates cell migration and invasion through the WNT/β-catenin pathway in pancreatic ductal adenocarcinoma
Pterostilbene enhances Osimertinib sensitivity in non-small cell lung cancer through FGFR4-dependent ferroptosis
Shared inflammatory-metabolic transcriptional effects in tubulointerstitial fibrosis and clear cell renal cell carcinoma
A mature tertiary lymphoid structure-associated spatial niche is inversely associated with ACC1-related lipid metabolism in neoadjuvant-treated hepatocellular carcinoma
Single-cell spatial transcriptomics identifies SERPINE1 as a vascular endothelial mediator of cisplatin resistance in head and neck squamous cell carcinoma
A renal cyst-clear cell renal cell carcinoma comorbidity analysis identifies a FOXM1-positive epithelial COL6A1-CD44 axis that remodels fibroblasts
Patient-derived gastric cancer organoids for functional precision oncology: disease-specific bottlenecks and clinical readiness
Single-cell transcriptomic and immune microenvironment analyses reveal a TIMP1-associated OLFM4⁺ tumor epithelial program linked to colorectal cancer progression and immune evasion
Single-cell and spatial transcriptomics reveal a DLL4-associated tip-like endothelial niche linked to neoadjuvant chemotherapy non-response in muscle-invasive bladder cancer
Cell-resolved spatial mapping of antibody-drug conjugate targets in breast cancer
Hypoxia-induced SATB homeobox 2 increases hypoxia-inducible factor-1-dependent tumorigenesis and drives bevacizumab resistance in lung adenocarcinoma
Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis/relapse in osteosarcoma
PiRNA-Hsap_1847317 may serve as a novel biomarker of PD-1 inhibitor resistance in patients with advanced non-small cell lung cancer
NR3C2 suppresses triple-negative breast cancer progression by regulating mitochondrial ROS homeostasis via NDUFB3
The CARM1–YIPF2 axis drives breast cancer progression and predicts poor prognosis
Soluble N-terminal EphA2 fragment as a diagnostic biomarker and functional mediator of tumor progression in triple-negative breast cancer
Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma
Network pharmacology and single-cell sequencing analysis of gastrodin in anticancer effects against colorectal cancer by regulating key target genes and the tumor immune microenvironment
Single-cell and bulk transcriptomic analysis of inflammation-metabolism programs and the tumor microenvironment of colorectal cancer liver metastasis
Machine learning and multi-omics analyses reveal CLDN1 as a candidate marker associated with colorectal cancer invasion and nutlin-3a (−) response
A multivariate plasma biomarker model for glioblastoma exclusion: a retrospective case-control study
Cell-free DNA fragmentomics and epigenomic profiling in hematologic malignancies: current evidence, translational limitations, and future directions
EUVIMED